Episodios

  • Venture: Scott Huennekens on The Worst Deals of His Career and What Medtech Leaders Can Learn from them
    Sep 17 2025

    Every leader has scars from bad decisions. Scott Huennekens, medtech’s “GOAT operator” and board veteran, shares the toughest lessons from his career, including the worst deals he ever made.

    We cover the six pack of mistakes, why culture and fit matter more than numbers, and how these failures shaped his approach to leadership, boards, and building value.


    Episode Breakdown:

    00:00 – Opening: why failure stories matter more than success stories

    01:12 – Introducing Scott Huennekens and his track record in medtech

    03:05 – The six pack of mistakes leaders repeat

    05:18 – Lesson one: falling in love with the technology, not the team

    07:42 – Lesson two: underestimating how long reimbursement takes

    10:03 – Lesson three: chasing markets too early

    13:20 – The five worst deals Scott ever made

    17:11 – Case one: wrong founder, wrong fit

    20:34 – Case two: technology ahead of its time

    23:40 – Case three: too much money raised, no discipline

    27:28 – Case four: ignoring culture red flags

    32:00 – Case five: strategic partnerships gone wrong

    37:41 – Why great boards matter in preventing bad decisions

    42:15 – How humility and honesty shape leadership

    46:54 – Advice for founders on picking investors and partners

    49:38 – Final thoughts: learning from scars, not slides


    Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

    Subscribe to our Youtube Channel

    ⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠

    Subscribe to our LinkedIn Newsletter

    ⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠

    Follow The State of MedTech on

    LinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠

    X ⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠

    Follow Omar M. Khateeb on

    LinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠

    X ⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠

    #Medtech #Leadership #ScottHuennekens #Healthcare #MedicalDevices #Entrepreneurship

    Más Menos
    1 h y 22 m
  • Stroke: Dr. Thomas Devlin on Robotic TCD, Stroke Workflows, & Detecting Missed PFOs
    Sep 15 2025

    Why are so many strokes in young patients missed? Dr. Thomas Devlin, nationally recognized stroke neurologist and executive medical director at CHI Memorial, explains how robotic transcranial Doppler (TCD) is reshaping stroke and PFO pathways.

    We cover why TCD is more sensitive than traditional echo, what the Bubble Trial revealed, and how robotic automation is changing workflows in neurology and cardiology.


    Episode Breakdown

    00:00 – Opening and the challenge of detecting PFO with echo

    01:11 – Introducing Dr. Thomas Devlin and the Bubble Trial

    03:01 – Why strokes in young patients often go unexplained

    05:25 – EEG vs robotic TCD: sensitivity and workflow

    07:09 – Why PFO must always stay on the differential

    10:13 – Meta-analyses and limitations of echo sensitivity

    12:29 – Advantages of robotic TCD and real-world performance

    15:46 – Benefits for techs and labs: automation and ease of use

    16:06 – The Bubble Trial: robotic TCD detects 3x more large shunts

    18:02 – Case study: negative echo, positive robotic TCD, large PFO

    19:41 – Editorial response and the call for independent validation

    20:16 – The Bubble-QE study: real-world validation and outcomes

    22:53 – Multicenter results: robotic TCD vs echo and TEE

    24:11 – Integrating robotic TCD into national cryptogenic stroke protocols

    26:50 – How the Pascal score guides closure decisions

    30:00 – Economics: reimbursement and hospital adoption

    33:05 – Building trust between neurologists and cardiologists

    35:00 – Guidelines and national rollout of robotic TCD

    37:05 – Comparing manual vs robotic: why automation wins

    42:54 – Structure, incentives, and improving stroke workups

    46:47 – Who “owns” the neurovascular lab: neurology vs cardiology

    50:16 – Reimbursement and payer considerations 55:38 – Lessons from emerging economies and value-based innovation

    58:13 – Future use cases: ambulance, helicopter, and OR monitoring

    1:03:34 – Final thoughts and why this is the third chapter of stroke innovation

    Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

    Subscribe to our Youtube Channel

    ⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠

    Subscribe to our LinkedIn Newsletter

    ⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠

    Follow The State of MedTech on

    LinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠

    X ⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠

    Follow Omar M. Khateeb on

    LinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠

    X ⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠


    #Stroke #Medtech #PFO #Robotics #Diagnostics #HealthcareInnovation


    Más Menos
    1 h y 10 m
  • Wound Care: Preventing Diabetic Amputations: Modulim CEO Amaan Mazhar on Imaging and Early Detection
    Sep 14 2025
    Every 20 seconds, someone in the world loses a limb to diabetes. Many of these amputations could be prevented with earlier detection. In this episode, Amaan Mazhar, CEO of Modulim, explains how handheld imaging can spot circulation issues before ulcers form. We cover the science behind spatial frequency domain imaging, the economics of diabetic foot ulcers, and how proactive screening can save both lives and costs.Episode Breakdown00:00 – The epidemic of lower limb complications in the US 02:01 – Amaan Mazhar’s journey into medtech and imaging science 03:38 – From UC Irvine research to founding Modulim 04:52 – Diabetic foot ulcers and why they are so costly 05:27 – Traditional foot checks and why they often fail 07:02 – Modulim’s imaging: seeing below the skin surface 09:17 – Biomarkers that predict wounds before they form 10:52 – Case study: detecting an ulcer 13 weeks before it appeared 12:06 – Spatial frequency domain imaging explained 13:23 – Pivot from cart system to handheld device 15:54 – Reducing manufacturing costs and expanding access 17:18 – Identifying micro vs macrovascular issues18:55 – Clinical traction with Kaiser Permanente and Fresenius 20:27 – Commercial model: hardware placement plus software subscription 22:01 – Expanding into military use for wound and burn assessment 25:03 – How the technology works: light patterns, multispectral imaging 27:21 – IP, UC Irvine partnership, and innovation pathway 28:10 – Regulatory strategy: 510(k) submission for handheld device29:35 – Market opportunity: 30–40 million patients at risk 31:04 – Early detection as a data gap and how Modulim can close it 32:28 – Closing thoughts and call to actionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channel⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠Subscribe to our LinkedIn Newsletter⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠Follow The State of MedTech onLinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠Follow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠⁠#Medtech #Diabetes #AmputationPrevention #Diagnostics #HealthcareInnovation #DigitalHealth
    Más Menos
    33 m
  • Cardiology: Mayo Clinic’s Dr. Mohamad Alkhouli on AI and the Future of Cardiology
    Sep 12 2025

    What does it take to close the innovation gap in cardiology? Dr. Mohamad Alkhouli, professor of medicine and vice chair for strategic partnerships at Mayo Clinic, shares his perspective on AI, health span vs lifespan, and why structure drives behavior in healthcare.

    This episode covers the future of multimodal AI, global innovation, and why doctors who embrace AI will lead the next generation of medicine.

    Episode Breakdown

    00:00 – Opening: AI as a personal coach and changing education

    01:11 – Introducing Dr. Mohamad Alkhouli and Mayo Clinic Innovation Summit

    03:01 – The innovation gap in cardiology explained

    03:38 – Lifespan vs health span and the 11-year gap

    04:11 – The cost of innovation and unsustainable healthcare spending

    07:09 – Three main reasons behind the innovation gap

    08:18 – Population-based models vs individual realities

    09:04 – The problem with fragmentation in medicine

    11:14 – Why grounding in pathophysiology matters

    16:16 – From AI skepticism to embracing its role in decision-making

    17:48 – Lessons from Waymo and the “extra eyes” analogy

    20:29 – AI in code: new insights from old angiograms

    22:28 – Multimodal AI and the future of cardiology diagnostics

    25:27 – Why multimodal biomarkers will redefine disease classification

    27:01 – How AI already improves procedural safety

    28:02 – Mayo Clinic’s in-house AI models and the Mayo Clinic Platform

    29:49 – Salience mapping and explainable AI

    32:40 – AI in medical education and generational differences

    36:18 – Redefining health: from WHO 1948 to dynamic health models

    42:54 – Structure drives behavior in innovation and healthcare systems

    45:20 – Democratizing innovation and involving frontline clinicians

    48:06 – Why reimbursement and payer models matter for adoption

    50:16 – ECG-based AI detection of aortic stenosis

    52:09 – Pushback from payers and systemic barriers

    55:38 – Value-based innovation and lessons from emerging economies

    58:13 – Planning the next Mayo Clinic Innovation Summit

    1:01:03 – The role of AI in connecting specialties and future training

    1:02:25 – The Mayo AI Summit and opportunities to join

    1:03:34 – Final thoughts: doctors who use AI vs doctors who don’t

    1:04:22 – What’s in your AI stack? Omar and Dr. Alkhouli share their tools


    Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠⁠ to book time for a free analysis.

    Subscribe to our Youtube Channel

    ⁠⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠⁠

    Subscribe to our LinkedIn Newsletter

    ⁠⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠⁠

    Follow The State of MedTech on

    LinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠⁠

    X ⁠⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠⁠

    Follow Omar M. Khateeb on

    LinkedIn ⁠⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠⁠

    X ⁠⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠


    #AI #Cardiology #Medtech #MayoClinic #DigitalHealth

    Más Menos
    1 h y 7 m
  • From Insomnia to Innovation: Moonbird CEO Stephanie Broes on Breathwork and Sleep
    Sep 8 2025
    Stephanie Broes, CEO and co-founder of Moonbird, shares how breathwork can improve sleep, stress, and HRV.From insomnia during her PhD to creating a tactile breathing device, Stephanie explains how science and design came together to build a product that is helping adults, children, and even parents navigate stress and rest.Episode Breakdown: 00:00 – How changing your breathing changes your sleep and mood01:21 – Meet Stephanie Broes and the story of Moonbird02:59 – From PhD scientist to health tech entrepreneur04:52 – Insomnia, stress, and the discovery of breathwork06:22 – Designing Moonbird and why the avocado shape worked10:33 – The story behind the Moonbird name12:05 – Breathwork and the nervous system explained15:13 – Heart rate variability (HRV) and why it matters17:04 – How Moonbird boosts HRV and supports sleep19:00 – Unexpected users: kids, ADHD, menopause, autism22:01 – Launching Moonbuddy for children25:22 – Co-creating products with parents and clinicians27:05 – Wellness market growth and scaling in the US29:00 – Marketing lessons: ads, PR, partnerships, insurance31:04 – Consumer vs. medical device strategy32:29 – Using Moonbird with or without the app33:19 – Real-time HRV, coherence, and biofeedback34:40 – Clinical studies and published results36:52 – Long-term vision: making breathwork mainstream39:08 – Handling criticism: “Why buy what’s free?”42:15 – Roadmap: AI, personalization, and integration with wearables43:30 – Closing thoughts and call to actionAre you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠⁠ to book time for a free analysis.Subscribe to our Youtube Channel⁠⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠⁠Subscribe to our LinkedIn Newsletter⁠⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠⁠Follow The State of MedTech onLinkedIn ⁠⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠⁠Follow Omar M. Khateeb onLinkedIn ⁠⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠⁠Instagram ⁠⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠⁠TikTok ⁠⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠⁠X ⁠⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠⁠Facebook ⁠⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠#Breathwork #Sleep #Moonbird #StressRelief #Medtech #DigitalHealth #Wellness
    Más Menos
    44 m
  • NFL Veteran Leonard Wheeler on Beating Prostate Cancer and Why Men Must Stop Waiting
    Sep 4 2025

    NFL veteran Leonard Wheeler opens up about his prostate cancer journey, from early PSA screening to diagnosis and the treatment decision that preserved both his health and quality of life.

    He talks about conversations with family, facing fear, recovery, and why men must start speaking openly about prostate cancer.Episode Breakdown

    00:00 – Opening: No signs, just rising PSA trends

    01:02 – Meet Leonard Wheeler: NFL career and life after football

    05:11 – PSA checks, biopsy, and the moment fear set in

    08:55 – Talking with family: wife, children, and support system

    13:00 – Shame, silence, and why men struggle to share health news

    17:05 – From prostatectomy options to learning about ablation

    22:23 – Fear of side effects: continence, intimacy, and identity

    25:04 – A friend introduces the idea of focal therapy

    27:10 – Why a minimally invasive procedure became the choice

    30:45 – Recovery: catheter, walking miles, and regaining confidence

    33:12 – Faith, friends, and a dream of advocacy

    36:00 – Explaining the procedure step by step

    42:30 – Quality-of-life focus: protecting intimacy and dignity

    46:14 – Family, prayer circles, and the role of support networks

    49:11 – Why men do not talk about prostate cancer and why they must

    52:24 – Creating a movement: awareness, ribbons, and brotherhood

    55:07 – Leonard’s book Beyond the Locker Room and his mission

    Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠⁠GrowMyMedtech.com⁠⁠⁠⁠ to book time for a free analysis.

    Subscribe to our Youtube Channel

    ⁠⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠⁠

    Subscribe to our LinkedIn Newsletter

    ⁠⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠⁠

    Follow The State of MedTech on

    LinkedIn ⁠⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠⁠

    X ⁠⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠⁠

    Follow Omar M. Khateeb on

    LinkedIn ⁠⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠⁠

    Instagram ⁠⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠⁠

    TikTok ⁠⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠⁠

    X ⁠⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠⁠

    Facebook ⁠⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠⁠

    #Medtech #LungCancer #Diagnostics #Pulmonology #HealthcareInnovation

    Más Menos
    1 h
  • Impact of Metabolic Activity Driving Precision in Diagnostic Bronchoscopy with Dr. Steven Kovacs
    Aug 30 2025

    Lung cancer remains the most lethal cancer worldwide, and traditional biopsy approaches still leave critical gaps. In this episode, interventional pulmonologist Dr. Steven Kovacs shares how real-time metabolic imaging inside the bronchoscopy suite is transforming how clinicians assess biopsy adequacy.

    Episode Breakdown

    00:00 – Opening remarks: the challenge of lung cancer diagnosis

    01:17 – Introducing Dr. Steven Kovacs

    02:11 – Journey through bronchoscopy: from navigation to robotics

    05:11 – The problem with current biopsy yields and ROSE

    07:29 – Why imaging tool-in-lesion is not enough

    09:59 – Metabolic activity as a new “PET scan for cells”

    12:16 – How dynamic cell imaging works in real time

    14:45 – Preserving tissue for pathology and sequencing

    17:15 – Differentiating inflammation, necrosis, and malignancy in the same lesion

    19:37 – Case studies: when pathology said “negative,” but malignancy was present

    22:01 – Adequacy as a clinical responsibility, not just pathology’s burden

    24:07 – The future of bronchoscopy workflows and precision medicine

    27:32 – Audience Q&A: diagnostic adequacy and workflow efficiency

    30:52 – Audience Q&A: reducing procedure time and anesthesia costs

    34:41 – Audience Q&A: handling tissue and specimen prep

    38:18 – Audience Q&A: impact on indeterminate biopsies

    43:12 – Audience Q&A: adequacy for NGS and downstream testing

    47:20 – Hospital administration and value analysis: time savings and cost impact

    50:05 – Surgical use cases and margin evaluation

    52:25 – Adoption and workflow integration: overcoming learning curves

    53:32 – Closing thanks and replay reminder


    Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠⁠GrowMyMedtech.com⁠⁠⁠ to book time for a free analysis.

    Subscribe to our Youtube Channel

    ⁠⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠⁠

    Subscribe to our LinkedIn Newsletter

    ⁠⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠⁠

    Follow The State of MedTech on

    LinkedIn ⁠⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠⁠

    Instagram ⁠⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠⁠

    TikTok ⁠⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠⁠

    X ⁠⁠⁠https://twitter.com/StateofMedTech⁠⁠⁠

    Facebook ⁠⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠⁠

    Follow Omar M. Khateeb on

    LinkedIn ⁠⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠⁠

    Instagram ⁠⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠⁠

    TikTok ⁠⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠⁠

    X ⁠⁠⁠https://twitter.com/OmarMKhateeb⁠⁠⁠

    Facebook ⁠⁠⁠https://www.facebook.com/OmarMKhateeb/⁠⁠

    #Medtech #LungCancer #Diagnostics #Pulmonology #HealthcareInnovation

    Más Menos
    54 m
  • Non-Surgical BCIs: Subsense CEO Tetiana Aleksandrova on Neurodegeneration and Cognitive Enhancement
    Aug 26 2025

    Tetiana Aleksandrova, CEO and founder of Subsense, explains how her team is building a nanoparticle-based Brain Computer Interface designed to treat symptoms of neurological disorders while unlocking new possibilities for human cognition.

    Episode Breakdown:00:00 – Opening and long-term vision for merging humans with technology01:10 – Guest introduction: Tetiana Aleksandrova, CEO and founder of Subsense
    02:01 – Personal journey: from chemistry to economics to serial BCI entrepreneur03:38 – Lessons learned from her first EEG-based BCI company05:25 – Why Subsense pivoted to nanoparticle-based BCIs06:52 – The problem with current treatments for neurodegenerative diseases07:40 – Non-surgical alternatives to deep brain stimulation09:35 – Nanoparticles as antennas for brain signals12:20 – Duration, delivery methods, and safety of nanoparticles13:04 – First clinical targets: Parkinson’s and epilepsy14:50 – Why non-surgical BCIs excite clinicians and investors16:05 – Expanding into broader neurological disorders and cognitive enhancement17:02 – Device design and hardware considerations18:19 – Why separate nanoparticles are needed for reading and stimulation20:01 – Collaborations with UC Santa Cruz and ETH Zurich21:08 – Regulatory challenges and breakthrough designation pathway22:21 – How stimulation nanoparticles work in the brain25:01 – Potential beyond medicine: memory, focus, and human performance28:14 – Public demand for cognitive optimization since COVID
    30:33 – The AI revolution and parallels with the BCI revolution
    33:01 – Why BCIs could be the next major technological shift
    34:20 – $17M funding round led by Golden Falcon Capital and Palo Alto lab launch
    36:45 – Future milestones and how to connect with Subsense

    Are you a medtech CEO in need of some marketing help attracting investors, growing sales pipeline, and more? Go to ⁠⁠GrowMyMedtech.com⁠⁠ to book time for a free analysis.

    Subscribe to our Youtube Channel

    ⁠⁠https://www.youtube.com/channel/UCGpL_rGt1LQJwinMq_K7gfg⁠⁠

    Subscribe to our LinkedIn Newsletter

    ⁠⁠https://www.stateofmedtechpodcast.com/⁠⁠

    Follow The State of MedTech on

    LinkedIn ⁠⁠https://www.linkedin.com/company/thestateofmedtech⁠⁠

    Instagram ⁠⁠https://www.instagram.com/stateofmedtech/⁠⁠

    TikTok ⁠⁠https://www.tiktok.com/@stateofmedtech⁠⁠

    X ⁠⁠https://twitter.com/StateofMedTech⁠⁠

    Facebook ⁠⁠https://www.facebook.com/stateofmedtech/⁠⁠

    Follow Omar M. Khateeb on

    LinkedIn ⁠⁠https://www.linkedin.com/in/okhateeb/⁠⁠

    Instagram ⁠⁠https://www.instagram.com/omar.m.khateeb/⁠⁠

    TikTok ⁠⁠https://www.tiktok.com/@omarkhateebofficial⁠⁠

    X ⁠⁠https://twitter.com/OmarMKhateeb⁠⁠

    Facebook ⁠⁠https://www.facebook.com/OmarMKhateeb/⁠

    #BCI #Neurotech #Medtech #HealthcareInnovation #BrainComputerInterface #DigitalHealth #Neuroscience


    Más Menos
    37 m